Natus Medical Incorporated (NTUS)
| Market Cap | 973.58M |
| Revenue (ttm) | 415.68M |
| Net Income (ttm) | -16.61M |
| Shares Out | 33.56M |
| EPS (ttm) | -0.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 22 |
| Last Price | $26.71 |
| Previous Close | $27.62 |
| Change ($) | -0.91 |
| Change (%) | -3.29% |
| Day's Open | 27.74 |
| Day's Range | 26.66 - 27.85 |
| Day's Volume | 183,437 |
| 52-Week Range | 16.38 - 28.83 |
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...
It is imperative to build a portfolio of low-beta stocks to sail through the choppy market. RCKY, STMP, OMI, NTUS & TM are the frontrunners.
Low-beta stocks may be able to help sail through the choppy market conditions.
To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.
Natus Medical (NTUS) delivered earnings and revenue surprises of 62.50% and 0.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...
Natus Medical (NASDAQ:NTUS) announces its next round of earnings this Thursday, February 25. Here is Benzinga's look at Natus Medical's Q4 earnings report.
PLEASANTON, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...
PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
PLEASANTON, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tr...
PLEASANTON, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...
Natus Medical (NTUS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Natus Medical (NTUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2020 Results - Earnings Call Transcript
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2020 Results - Earnings Call Transcript
Natus Medical (NTUS) delivered earnings and revenue surprises of 800.00% and 8.90%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
PLEASANTON, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...
Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PLEASANTON, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and...
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript
Natus Medical (NTUS) delivered earnings and revenue surprises of -360.00% and -13.67%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
PLEASANTON, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PLEASANTON, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...
What should investors think of this infant care and neurology specialist?
Partnership to advance the development and distribution of innovative AutoSCORE algorithm Partnership to advance the development and distribution of innovative AutoSCORE algorithm
PLEASANTON, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...
Another key partner joins the Otocloud community, expanding the reach even further.
PLEASANTON, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...
About NTUS
Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and n... [Read more...]
| Industry Medical Devices | Founded 1987 |
| CEO Jonathan Kennedy | Employees 1,420 |
| Stock Exchange NASDAQ | Ticker Symbol NTUS |
Financial Performance
In 2020, Natus Medical's revenue was $415.68 million, a decrease of -16.05% compared to the previous year's $495.18 million. Losses were -$16.61 million, 6.01% more than in 2019.
Analyst Forecasts
The average 12-month stock price forecast for Natus Medical is 36.00, which is an increase of 34.78% from the latest price.